Regular ArticleExpression of Human Cytochrome P450 2B6 in Escherichia coli: Characterization of Catalytic Activity and Expression Levels in Human Liver☆
References (53)
- et al.
Pharmacol. Ther.
(1990) - et al.
J. Biol. Chem.
(1993) - et al.
J. Biol. Chem.
(1984) - et al.
Arch. Biochem. Biophys.
(1998) - et al.
Arch. Biochem. Biophys.
(1980) Methods Enzymol.
(1991)- et al.
Biochem. Pharmacol.
(1998) - et al.
Biochem. Pharmacol.
(1996) - et al.
Arch. Biochem. Biophys.
(1994) - et al.
Arch. Biochem. Biophys.
(1993)
J. Biol. Chem.
Biochem. Pharmacol.
Arch. Biochem. Biophys.
J. Biol. Chem.
Anal. Biochem.
Arch. Biochem. Biophys.
Arch. Biochem. Biophys.
J. Biol. Chem.
J. Biol. Chem.
Biochem. Pharmacol.
Pharmacol. Rev.
Biochem. Pharmacol.
Carcinogenesis
Biochemistry
Mol. Pharmacol.
Mol. Pharmacol.
Cited by (116)
Functional expression and regulation of eukaryotic cytochrome P450 enzymes in surrogate microbial cell factories
2022, Engineering MicrobiologyConstitutive androstane receptor mediates PCB-induced disruption of retinoid homeostasis
2019, Toxicology and Applied PharmacologyInhibitory effect of α-terpinyl acetate on cytochrome P450 2B6 enzymatic activity
2018, Chemico-Biological InteractionsCharacterization of Cytochrome P450 Enzymes and Their Applications in Synthetic Biology
2018, Methods in EnzymologyCitation Excerpt :Once again, a C-terminal His-tag is included to facilitate purification (Barnes et al., 1991). Examples utilizing the CYP17A1 consensus sequence include studies of rabbit CYP4B1 (Cheesman, Baer, Zheng, Gillam, & Rettie, 2003) and human CYP2B6 (Hanna, Reed, Guengerich, & Hollenberg, 2000). There are also some notable exceptions in which the N-terminus is not modified.
Effect of genetic polymorphism of human CYP2B6 on the metabolic activation of chlorpyrifos
2018, Pesticide Biochemistry and Physiology
- ☆
This study was supported in part by USPHS Grants R35 CA44353 and P30 ES00267 (F.P.G.) and R01 CA16954 (P.F.H.). I.H.H. was supported in part by National Research Service Award F32 CA79162 from the National Institutes of Health.
- 2
To whom correspondence may be addressed at Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, 638 Medical Research Building I, 23rd and Pierce Avenues, Nashville, TN 37232-0146. Fax: (615) 322-3141. E-mail: [email protected].
- 3
To whom correspondence may be addressed at Department of Pharmacology, 2301 Medical Sciences Research Building III, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0632. Fax: (734) 763-4450. E-mail: [email protected].